{"id":127294,"name":"TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY)","slug":"tiber-creek-health-strategies-inc-on-behalf-of-eli-lilly-and-company","state":"DC","description":"Pharmaceutical company.","totalSpending":1200000,"filings":18,"yearlySpending":[{"year":2020,"income":160000},{"year":2021,"income":180000},{"year":2022,"income":300000},{"year":2024,"income":320000},{"year":2025,"income":240000}],"firms":["TIBER CREEK GROUP"],"lobbyists":["JONATHON JONES","JOHN GONZALEZ","ANDREW MCKECHNIE","JENNIFER OLSON","EMILY KIRLIN","BRYANT HALL","TIMOTHY MOLINO","COREY MALMGREN"],"issues":["HCR","MMM","IMM","TRD","TAX","CPT","BUD","ENG"],"sampleDescriptions":["Issues related to drug pricing.","Issues related to drug pricing. HR 6201 Families First Coronavirus Response Act (PL 116-27); CARES Act - S. 3548 (PL 116-136)","CARES Act - S. 3548 (PL 116-136) - drug pricing issues. H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions Act","Issues related to non-immigrant visa restrictions","Issues related to drug pricing, reimbursement for prescription drugs, and the pharmaceutical supply chain; Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act; HR 4100/S 1712 DISARM Act; Executive Order on Lowering Drug Prices by Putting America First","Issues related to drug pricing, reimbursement for prescription drugs, and the pharmaceutical supply chain; Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act; HR 4100/S 1712 DISARM Act; Executive Order on Lowering Drug Prices by Putting America First; H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act; Issues related to the Medicaid Drug Rebate Program","Issues relating to US intellectual property laws.","Issues related to drug pricing, reimbursement for prescription drugs, and the pharmaceutical supply chain; Issues related to the American Families Plan; H.R. 2873 Affordable Prescriptions for Patients Through Promoting Competition Act; S.1435 Affordable Prescriptions for Patients Act of 2021.","Issues related to the federal tax treatment of Global Intangible Low-Taxed Income (GILTI).","H.R. 2873 - Affordable Prescriptions for Patients Through Promoting Competition Act of 2021; S.1435 - Affordable Prescriptions for Patients Act of 2021; H.R. 2891 - Preserve Access to Affordable Generics and Biosimilars Act.","Issues related to drug pricing and reimbursement for prescription drugs; Issues related to the American Families Plan; S. Con Res 14; S. 2199  - the Insulin Price Reduction Act (116th Congress); S. 596/H.R. 1577 - Treat and Reduce Obesity Act of 2021; H.R. 5260 - Reduced Costs and Continued Cures Act.","Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); Issues related to the American Families Plan; S. Con Res 14; S. 596/H.R. 1577 - Treat and Reduce Obesity Act of 2021.","Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); Issues related to the American Families Plan; S. Con Res 14; Issues related to Consolidated Appropriations Act, 2022 (PL 117-103); Issues related to proposed national coverage decision (NCD) for Medicare beneficiaries with Alzheimers.","H.R. 2891 - Preserve Access to Affordable Generics and Biosimilars Act.","Issues relating to drug pricing; H.R. 6833/S. 3700 - Affordable Insulin Now Act.","Funding for therapeutics to be included in the Consolidated Appropriations Act, 2022 (PL 117-103).","Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); Issues related to the American Families Plan; S. Con Res 14; Issues related to Consolidated Appropriations Act, 2022 (PL 117-103).","Issues relating to drug pricing; H.R. 6833/S. 3700 - Affordable Insulin Now Act; Improving Needed Safeguards for Users of Lifesaving Insulin Now Act.","Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); Issues related to the American Families Plan; S. Con Res 14; Issues related to Consolidated Appropriations Act, 2022 (PL 117-103); Inflation Reduction Act of 2022 (PL 117-169).","Issues relating to drug pricing; H.R. 6833/S. 3700 - Affordable Insulin Now Act; Improving Needed Safeguards for Users of Lifesaving Insulin Now Act; The legislative vehicle for the Continuing Resolution (PL 117-180)."],"years":[2020,2021,2022,2024,2025]}